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Death frOnt pneumonia in young children - time for action
~ute respiratory infections (ARls) are a leadingcause of death in South African children.' Mostof these deaths are from pneumonia and are
potentially preventable, bur the necessary steps to
address the problem have not been taken. In this South
Africa lags behind much of the industrialised world and
several African countries.
In a recent study, based on national mortality data
provided by the Central Statistical Services, pneumonia
ranked second only to gastro-enteritis as a killer of
South African children younger than 4 years of age.'
Risk factors for death from pneumonia are malnutrition,
crowding, low birth weight and indoor pollution from
domestic fuel combustion and tobacco smoke.' The lack
of a good primary health care system, inaccessibility of
hospital facilities to many rural communities, poor
immunisation coverage, and lack of marernal health
education also contribute. In South Africa, where race is
a determinant of socio-economic status, black children
are at highest risk and have a death rate from pneu-
monia 270 times greater than that recorded for similarly
aged children in Western Europe.' Even for children
from the economically advantaged white group the risk
of dying from pneumonia was found to be 7 times
greater than that of their Western European counter-
parts.'
While one might quibble about the precision of these
dara,' they are the best available. Even if they are in
error by as much as 100%, which is very unlikely, these
figures would still be a devastating indicrrnem of our
health system and of our neglect of children.
ARls are the single most importam cause of child-
hood morbidity in South Africa and are a major drain
on ambulatory and inpatient health resources. ARIs
account for approximarely 40% of childhood consulta-
tions in both the private and public health sectors. 3 In
addition, ir is estimated that about 13 000 South African
children require hospitalisation for pneumonia each
year.' In up to half of these symptoms may recur and
radiographic abnormalities may persist. 4 Many will have
pennanently impaired lung function and be at risk for
chronic obstructive lung disease in adulthood.' Effective
treatment of childhood pneumonia may thus also
decrease debilitating lung disease among adults.·
Our predicament is not unique. On a global scale
ARl represents a public health problem of greater mag-
nirude than either adult heart disease or cancer. 7 The
World Health Organisation estimares that berween 25%
and 33% of all childhood deaths are attributable to
ARls - 4 million preventable childhood deaths from
pneumonia every year. What distinguishes the ARI
problem in South Africa from that of our neighbours is
our response to it: Zimbabwe (1987), Botswana (1989),
Lesotho (1990), and amibia (1990) have joined 38
other countries in the developing world in launching
national programmes to implement WHO guidelines for
the control of ARl, while we have not.
The WHO guidelines for reducing the morbidity and
mortality from ARl"" have three components: preven-
tive measures which include immunisation, health edu-
cation, and case management. The first step in case
management is the assessment of severity. Simple clini-
cal criteria are used. Children with a respiratory rate of
less than 40 breaths per minute (50 if younger than 1
year) are categorised as mild ARl. A respiratory rate of
more than 40 per minute indicates moderate ARI.
Children with severe ARI have tachypnoea, lower chest
wall retractions and are unable to take feeds. The guide-
lines recognise that in pneumonia the critical deter-
minants of outcome are antibiotic choice and the avail-
ability of oxygen. Children with mild ARI require only
symptomatic treatment, those with moderate ARI also
require antibiotics, and children with severe ARl require
hospital admission for parenteral antibiotics and oxygen
therapy.9-"
The choice of antibiotic is straightforward. The only
organisms of clinical importance in community-
acquired pneumonias in children are Srreptococcus pneu-
nzoniae, Haenzophilus influenzae and, in children who
had previously received antibiotics, Swphylococcus
aureus." These bacteria can be treated by cheap, widely
available antibiotics, such as amoxycillin and co-trirnox-
azole.
Oxygen therapy is more difficult. Hypoxia is the ulti-
mate cause of death in pneumonia. 13 But because of cost
and problems associated with rhe supply of oxygen
cylinders, routine oxygen therapy for children with
pneumonia remains a hypothetical intervention for chil-
dren in this country who live at a distance from a main
centre. Oxygen concentrators are a cost-effective alter-
native to cylinders, capable of reducing oxygen costs by
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every hospital which now relies on oxygen cylinders
should have at least two concentrators for use in children.
It is also important that the available oxygen be used
efficiently. Conventional delivery systems such as face
masks or head boxes often are nor well tOlerated and are
wasteful, requiring flow rates of 4 - 10 l/min. Oxygen
rents are not only wasteful but extremely unreliable and
should no longer be used for children. i5 Most children
with pneumonia can be adequately oxygenated \vith a
flow rate of only 0,5 - 1,0 l/min if delivered by a 6-8FG
catheter in the nose. Effective oxygen concentrations of
33 - 50% are achievable by this route" and humidifica-
tion is not necessary. Specific guidelines for the use of
oxygen concentratOrs and nasal oxygen therapy are cur-
rently under development by WHO and are expected to
be released later this year.
Although they are simple, the WHO guidelines for
the control of ARI are not a compromise. They are a
distillation of the best current clinical knowledge and
practice and are suitable for use in all children and by all
practitioners, whether they be community-based health
workers, '6 family practirioners or specialisrs. They
should be applied to all South African children as a mat-
ter of urgency. Elsewhere, they have been strikingly
effective at reducing mortality from ARI. A mera-analy-
sis of their implementation in developing countries
found a 35% reduction in pneumonia mortality in
infants below 1 year of age, and a 45% reduction in
children between 1 and 4 years of age. 17 The consequent
reduction in overall childhood mortality rate was 20 -
35%.17 This effect compares favourably with the 20%
reduction in childhood mortality by measles immunisa-
tion l ' and an 11 - 14% reduction in childhood mortality
by oral rehydration for childhood diarrhoea. 19 We esti-
mate on the basis of these results that a national ARI
programme could save the lives of 1 800 or more South
African children each year.
The introduction of a case management protocol for
ARI in South Africa holds tremendous potential advan-
tages and cost savings. It will improve the health of
children, rationalise the use of antimicrobials, preserve
antibiotic efficacy, lead to cost-effective use of oxygen
and reduce expenditure on ineffective therapies. \Xle call
on the Department of Health to appoint a task force
charged with the responsibility for implementing a
coherent ARI programme in South Africa.
The tools for reducing the appalling death rate and
morbidity from pneumonia in our country's children are
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Perspectives on AIDS control in ZaJ:nbia
~e first cases of AIDS in Zambia probablyoccurred in the early 1980s.'-3 Initially an urbanproblem, AIDS has spread to rural areas of
Zambia4 as in other African countries.; Given its impact
on the incidence and severity of endemic diseases such
as tuberculosis,.,7 malaria,S and Kaposi's sarcoma l ,9,IO
HIV infection has become a leading public health prob-
lem. Reduced morbidity and mortality rates before the
AIDS era are likely to be negated by secondary epi-
demics of communicable diseases like tuberculosis. 6,7
HIV infection in Zambia is mainly spread heterosexually
and has epidemiological similarities to and may be facili-
tated by conventional sexually transmined diseases
(STDS).ll-" If STD trends are used as proxy indicators
of trends in HIV infection, the country-wide rise in the
incidence of STDs in the mid-1980s1 4 implies that the
number of cases of AIDS may continue to rise for some
time even though subsequent transmission of HIV may
have declined since 1987. 15
The launching of the National AIDS Prevention and
Control Programme (NAPCP) in 1986, the immediate
task of which was to publicise the AIDS epidemic,
generated widespread public awareness. ID Subsequent
diversification of its activities has created a framework
for assertive AIDS control. The Zambian NAPCP has
performed its initial tasks well. However, even though
increasing public awareness, surveillance and clinical
support are very important the ultimate challenge is to
deal effectively with the root causes of sexual behaviour
which increase the risk of transmining or acquiring HIV.
